363 related articles for article (PubMed ID: 33111432)
1. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
[TBL] [Abstract][Full Text] [Related]
2. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
3. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
[TBL] [Abstract][Full Text] [Related]
4. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
[TBL] [Abstract][Full Text] [Related]
5. Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.
Fibla JJ; Cassivi SD; Brunelli A; Decker PA; Allen MS; Darling GE; Landreneau RJ; Putnam JB
Lung Cancer; 2012 Dec; 78(3):259-62. PubMed ID: 23040416
[TBL] [Abstract][Full Text] [Related]
6. Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Kim BG; Choi J; Lee SK; Choi SI; Park CK; Sim JK; Lee H; Kim SH; Sohn JW; Yoon HJ; Lee SY; Park DW
J Thorac Dis; 2024 Feb; 16(2):875-883. PubMed ID: 38505035
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification and adjuvant chemotherapy after radical resection based on the clinical risk scores of patients with stage IB-IIA non-small cell lung cancer.
Zhai W; Duan F; Li D; Yan Q; Dai S; Zhang B; Wang J
Eur J Surg Oncol; 2022 Apr; 48(4):752-760. PubMed ID: 34620508
[TBL] [Abstract][Full Text] [Related]
8. Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC.
Shen ZQ; Feng KP; Fang ZY; Xia T; Pan S; Ding C; Xu C; Ju S; Chen J; Li C; Zhao J
J Cardiothorac Surg; 2024 Jan; 19(1):1. PubMed ID: 38166960
[TBL] [Abstract][Full Text] [Related]
9. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
Front Oncol; 2021; 11():784289. PubMed ID: 35155190
[TBL] [Abstract][Full Text] [Related]
10. Impact of age on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancer.
Zhai X; Yang L; Chen S; Zheng Q; Wang Z
Cancer Med; 2016 Sep; 5(9):2286-93. PubMed ID: 27367482
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
Wightman SC; Lee JY; Ding L; Atay SM; Shemanski KA; McFadden PM; David EA; Kim AW
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325098
[TBL] [Abstract][Full Text] [Related]
12. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of visceral pleural invasion in the stage pT
Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
[TBL] [Abstract][Full Text] [Related]
14. Value of adjuvant chemotherapy for patients with pT2N0M0 non-small cell lung cancer receiving radical resection.
Chen S; Yang S; Zhao Y; Zhang Y; Huang Q; Wu H; Hu H; Sun Y; Zhang Y; Xiang J; Ye T; Chen H
Thorac Cancer; 2024 Jan; 15(3):258-265. PubMed ID: 38098268
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of TLR from FDG PET/CT in patients with margin-negative stage IB and IIA non-small cell lung cancer.
Park HL; Boo SH; Park SY; Moon SW; Yoo IR
Eur Radiol; 2023 Oct; 33(10):7274-7283. PubMed ID: 37060445
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: A propensity score-matched analysis of SEER database.
De Giglio A; Di Federico A; Gelsomino F; Ardizzoni A
Lung Cancer; 2021 Nov; 161():18-25. PubMed ID: 34492552
[TBL] [Abstract][Full Text] [Related]
17. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.
David E; Thall PF; Kalhor N; Hofstetter WL; Rice DC; Roth JA; Swisher SG; Walsh GL; Vaporciyan AA; Wei C; Mehran RJ
Ann Thorac Surg; 2013 Jun; 95(6):1872-7; discussion 1877. PubMed ID: 23643547
[TBL] [Abstract][Full Text] [Related]
18. Impact of adjuvant chemotherapy in stage IB non-small-cell lung cancer: an analysis of 112 consecutively treated patients.
Dediu M; Ion O; Ion R; Alexandru A; Median D; Gal C; Horvat T; Motas C; Motas N
J BUON; 2012; 17(2):317-22. PubMed ID: 22740212
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
[TBL] [Abstract][Full Text] [Related]
20. Lobe-specific analysis of perioperative chemotherapy for non-small cell lung cancer patients.
Lei X; Li T; Mao F; Ren F; Tang Q; Cao W; Zu L; Xu S
Cancer Med; 2023 Aug; 12(16):16896-16905. PubMed ID: 37403701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
